Suchergebnisse - "Asselah, Tarik"

PubPharm (38)

1

Nucleic Acid Polymers are Effective in Targeting Hepatitis B Surface Antigen, but More Trials Are Needed

enthalten in: Gastroenterology | 2020

von Durantel, D. | Asselah, T.

CommentOn: Gastroenterology. 2020 Jun;158(8):2180-2194. - PMID 32147484

2

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

enthalten in: PloS one | 2020

von Marcellin, P. | Xie, Q. | Woon Paik, S. | +14

3

An easy-to-use baseline scoring system to predict response to peginterferon alfa-2a in patients with chronic hepatitis B in resource-limited settings

enthalten in: Antiviral therapy | 2018

von Lampertico, P. | Messinger, D. | Oladipupo, H. | +3

4

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response

enthalten in: PloS one | 2017

von Asselah, T. | Moreno, C. | Sarrazin, C. | +12

5

Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin : Pooled Analysis of Data from Two Large, International Cohort Studies

enthalten in: Advances in therapy | 2016

von Asselah, T. | Esmat, G. | Sanai, F. | +4

6

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1 : pooled analysis of two phase 3 trials

enthalten in: Annals of hepatology | 2016

von Jensen, D. | Asselah, T. | Dieterich, D. | +27

7

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin

enthalten in: PloS one | 2016

von Asselah, T. | Thompson, A. | Flisiak, R. | +4

8

STARTVerso1 : A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection

enthalten in: Journal of hepatology | 2015

von Ferenci, P. | Asselah, T. | Foster, G. | +23

9

Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection : ANRS-HC25-VITAVIC study

enthalten in: World journal of gastroenterology | 2015

von Terrier, B. | Lapidus, N. | Pol, S. | +7

10

Optimism for patients with genotype 4 HCV infection : clinical trials with direct-acting antivirals finally available

enthalten in: Journal of hepatology | 2015

von Asselah, T.

CommentOn: J Hepatol. 2015 May;62(5):1040-6. - PMID 25450208